Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African Republic

Manirakiza, Alexandre; Kipela, Jean Marie; Sosler, Stephen; M'Bary Daba, Régis; Gouandjika-Vasilache, Ionela
January 2011
BMC Public Health;2011 Supplement 4, Vol. 11 Issue Suppl 4, p327
Academic Journal
Background: Passively acquired maternal antibodies are necessary to protect infants against circulating measles virus until they reach the eligible age of vaccination. Likewise, high levels of population immunity must be achieved and maintained to reduce measles virus transmission. This study was undertaken to (1) assess the presence of maternally acquired measles-specific IgG antibodies among infants less than 9 months of age in Bangui, Central African Republic and (2) determine the immune status of vaccination-age children and the concordance with reported vaccination status. A secondary objective was to describe the presence of rubella-specific IgG antibody in the study population. Methods: Vaccination history and blood samples were collected from 395 children using blotting paper. Samples were analyzed for the presence of measles-specific IgG antibodies using commercial ELISA kits. Results: Measles-specific IgG antibodies were detected in 51.3% of vaccinated children and 27.6% of nonvaccinated children. Maternally derived measles IgG antibodies were present in only 14.8% of infants aged 0-3 months and were absent in all infants aged 4-8 months. The presence of IgG-specific measles antibodies varied among children of vaccination age, from 57.3% for children aged 9 months to 5 years, to 50.6% for children aged 6-9 years and 45.6% for chidren aged 10 years and above. The overall prevalence of rubella-specific IgG was 55.4%, with a high prevalence (87.4%) among children over 10 years of age. Conclusion: The findings suggest that despite efforts to accelerate measles control by giving a second dose of measles vaccine, a large number of children remain susceptible to measles virus. Further research is required to determine the geographic extent of immunity gaps and the factors that influence immunity to measles virus in the Central African Republic.


Related Articles

  • Measles-Virus--Neutralizing Antibodies in Intravenous Immunoglobulins. Audet, Susette; Virata-Theimer, Maria Luisa; Beeler, Judy A.; Scott, Dorothy E.; Frazier, Douglas J.; Mikolajczyk, Malgorzata G.; Eller, Nancy; Feng-Ming Chen; Yu, Mei-Ying W. // Journal of Infectious Diseases;9/15/2006, Vol. 194 Issue 6, p781 

    Measles infection induces lifelong immunity; however, wild-type infection stimulates higher levels of measles-virus-neutralizing antibodies (mnAbs) than does vaccination. Because the proportion of the donor population with vaccine-induced measles immunity is increasing, this study was conducted...

  • Factors Determining Prevalence of Maternal Antibody to Measles Virus throughout Infancy: A Review. Caceres, Victor M.; Strebel, Peter M.; Sutter, Roland W. // Clinical Infectious Diseases;7/1/2000, Vol. 31 Issue 1, p110 

    Focuses on the determinants of the prevalence of maternal antibody to measles virus or measles maternal antibody (MMA) during infancy. Measurement of the starting level of maternal antibody; Factors influencing placental transfer of maternal antibody; Rate of decay of maternal antibody after...

  • Decrease in Measles Virus--Specific CD4 T Cell Memory in Vaccinated Subjects. Naniche, Denise; Garenne, Michel; Rae, Chris; Manchester, Marianne; Buchta, Richard; Brodine, Stephanie K.; Oldstone, Michael B. A. // Journal of Infectious Diseases;10/15/2004, Vol. 190 Issue 8, p1387 

    Since the licensure and generalization of an effective measles virus (MV) vaccine 41 years ago, antibody levels have been used as correlates of immunity. The long-lived MY-specific antibody response has been studied intensely, but the dynamics of MV-specific T cell immunity over time have not...

  • The Influence of HIV-1 Exposure and Infection on Levels of Passively Acquired Antibodies to Measles Virus in Zambian Infants. Scott, Susana; Moss, William J.; Cousens, Simon; Beeler, Judy A.; Audet, Susette A.; Mugala, Nanthalile; Quinn, Thomas C.; Griffin, Diane E.; Cutts, Felicity T. // Clinical Infectious Diseases;12/1/2007, Vol. 45 Issue 11, p1417 

    Background. The age at which passively acquired antibodies are lost is critical to determining the optimal age for measles vaccination. Little is known about the influence of human immunodeficiency virus type 1 (HIV-1) infection on levels of prevaccination antibodies to measles virus. Methods....

  • Protection against Challenge with Measles Virus (MV) in Infant Macaques by an MV DNA Vaccine Administered in the Presence of Neutralizing Antibody. Premenko-Lanier, Mary; Rota, Paul A.; Rhodes, Gary H.; Bellini, William J.; McChesney, Michael B. // Journal of Infectious Diseases;6/1/2004, Vol. 189 Issue 11, p2064 

    Measles virus (MV) infection is the major cause of vaccine-preventable death in infants and children worldwide. It is difficult to achieve immunity to MV infection by use of vaccines in infants during the first 6–9 months of life because of the presence of maternal antibody. Morbidity and...

  • Prevention of measles deaths in Darfur, Sudan.  // Weekly Epidemiological Record;9/17/2004, Vol. 79 Issue 38, p344 

    This article presents information on mortality due to measles in Darfur, Sudan. It is informed that in March and April 2004, the Expanded Programme on Immunization, in the Federal Ministry of Health in Sudan received reports of measles cases with high mortality in Western and Northern Darfur....

  • Global Measles Elimination Efforts: The Significance of Measles Elimination in the United States. Strebel, Peter M.; Henao-Restrepo, Ana-Maria; Hoekstra, Edward; Olivé, Jean-Marc; Papania, Mark J.; Cochi, Stephen L. // Journal of Infectious Diseases;5/1/2004 Supplement, Vol. 189, pS251 

    Lessons learned from the successful end of endemic measles virus transmission (i.e., elimination) in the United States include the critical roles of strong political commitment, a regionwide initiative, adequate funding, and a broad coalition of partners. Implications of measles elimination in...

  • Measles transmission following the tsunami in a population with a high one-dose vaccination coverage, Tamil Nadu, India 2004-2005. Mohan, Arumugam; Murhekar, Manoj V; Wairgkar, Niteen S; Hutin, Yvan J; Gupte, Mohan D // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p143 

    Background: On 26 December 2004, a tsunami struck the coast of the state of Tamil Nadu, India, where one-dose measles coverage exceeded 95%. On 29 December, supplemental measles immunization activities targeted children 6 to 60 months of age in affected villages. On 30 December, Cuddalore, a...

  • Recommendations for using MMR vaccine in children allergic to eggs. Khakoo, G A // BMJ: British Medical Journal (International Edition);04/01/2000, Vol. 320 Issue 7239, p929 

    Focuses on a study which dealt with using the allergic reactions caused by the Measles, Mumps, Rubella (MMR) vaccine in children in Great Britain. Information on the measles virus used in the MMR vaccine; Immunization guidelines in Great Britain; Constituents of MMR that may cause allergic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics